These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7537879)

  • 1. The influence of gravidity on Down's syndrome screening with free beta hCG.
    Spencer K
    Prenat Diagn; 1995 Jan; 15(1):87-9. PubMed ID: 7537879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Cuckle H
    Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of free beta-hCG in antenatal screening for Down's syndrome.
    Wald N; Densem J; Stone R; Cheng R
    Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
    Wald NJ; Densem JW
    Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-marker serum screening for Down's syndrome.
    Wald NJ; Densem JW; Smith D; Klee GG
    Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
    Watt HC; Wald NJ; Smith D; Kennard A; Densem J
    Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
    Spencer K; Salonen R; Muller F
    Prenat Diagn; 1994 Jul; 14(7):537-42. PubMed ID: 7526363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum free alpha- and free beta-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
    Wald NJ; Densem JW; Cheng R; Collishaw S
    Prenat Diagn; 1994 Sep; 14(9):835-7. PubMed ID: 7531328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
    Macri JN; Spencer K; Garver K; Buchanan PD; Say B; Carpenter NJ; Muller F; Boué A
    Prenat Diagn; 1994 Feb; 14(2):97-103. PubMed ID: 7514291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum screening for Down's syndrome.
    Bibby J; McCormack MJ
    Br J Obstet Gynaecol; 1994 Jun; 101(6):557-8. PubMed ID: 7517183
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
    Milunsky A; Nebiolo LM; Bellet D
    Fetal Diagn Ther; 1993; 8(4):221-4. PubMed ID: 7505085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening.
    Haddow JE; Palomaki GE; Knight GJ
    J Med Screen; 1995; 2(1):28-30. PubMed ID: 7497141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of smoking and parity on serum markers for Down's syndrome screening.
    Tislarić D; Brajenović-Milić B; Ristić S; Latin V; Zuvić-Butorac M; Bacić J; Petek M; Kapović M
    Fetal Diagn Ther; 2002; 17(1):17-21. PubMed ID: 11803210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
    Wald NJ; George L; Smith D; Densem JW; Petterson K
    Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.